Who invested in Chase Pharmaceuticals?
Chase Pharmaceuticals's investors include Edmond de Rothschild Venture Capital, Cipla and New Rhein Healthcare.

United States · Venture startup
Funding summaryUpdated 26 Oct 2026
$25Mraised across 3 rounds since 2010, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding recordSEC filing: $3.0M sold, first sale Aug 2015
Also list them on their own siteAndera Partners
From a historical funding recordSEC filing: $6.1M sold, first sale May 2014
No investor was named in the report.
Reported by sec.govSEC filing: $1.2M sold, first sale Nov 2010
From the SEC filings it signed: 2 on the team.
On the board, as filediJohn M. ReherKaroly N. NikolichNayan Greg ParekhRaphael M. WisniewskiStephen N. CunninghamVikram M. Sudarsan
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Chase Pharmaceuticals's investors include Edmond de Rothschild Venture Capital, Cipla and New Rhein Healthcare.
Chase Pharmaceuticals has raised $25M across 3 rounds since 2010.
Chase Pharmaceuticals's most recent round was a Venture of $3.0M in Aug 2015.
Chase Pharmaceuticals's largest round on record is $21M (Series B), in May 2014.
Chase Pharmaceuticals's first round on record, in May 2014, was backed by Edmond de Rothschild Venture Capital, Cipla and New Rhein Healthcare.
Chase Pharmaceuticals's latest named round is a Venture, in Aug 2015.
Chase Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.